Jun 26, 2026 01:30AM
Jun 26, 2026 01:30AM
May 20, 2026 02:45PM
Apr 1, 2026 01:30AM
Mar 31, 2026 01:30AM
Mar 23, 2026 01:00PM
Mar 23, 2026 01:00PM MaaT Pharma Presents the ARES Phase 3 Pivotal Trial Final Data During the Presidential Plenary Session at the 52nd Annual Meeting of the European Society for Bone and Marrow Transplantation
Mar 9, 2026 01:00PM
Dec 8, 2025 12:00PM
Dec 8, 2025 12:00PM
Nov 3, 2025 12:06PM
Nov 3, 2025 12:00PM
Sep 17, 2025 01:30AM
Jul 2, 2025 12:30PM MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe
Jun 19, 2025 01:00PM
Jun 2, 2025 12:30PM
Mar 27, 2025 02:30AM
Mar 18, 2025 01:00PM
Mar 11, 2025 01:30PM
Jan 8, 2025 01:30PM
Dec 9, 2024 08:30PM CORRECTING and REPLACING: MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Access Program at ASH 2024 Annual Meeting
Dec 9, 2024 12:00PM
Dec 5, 2024 12:00PM
Nov 7, 2024 01:30AM
Oct 15, 2024 01:30AM
Apr 15, 2024 01:30AM
Mar 28, 2024 01:00PM
Mar 5, 2024 01:30AM MaaT Pharma indicates completion of Patient Recruitment for the Phase 2a Investigator-Sponsored Randomized Clinical Trial Evaluating MaaT013 in Combination with Immune Checkpoint Inhibitors in Metasta
Dec 11, 2023 01:30AM
Sep 26, 2023 12:00PM
Jul 27, 2023 12:00PM
Jul 26, 2023 12:00PM
Jul 20, 2023 12:00PM
May 9, 2023 12:00PM
Apr 24, 2023 01:30AM MaaT Pharma Announces U.S. FDA Lifts Clinical Hold on Phase 3 Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease
Mar 30, 2023 12:00PM
Feb 3, 2023 01:30AM
Jan 24, 2023 12:00PM
Dec 10, 2022 11:30AM
Nov 29, 2022 12:00PM
Nov 8, 2022 12:00PM
Nov 3, 2022 01:00PM MaaT Pharma Announces Oral and Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting
Sep 29, 2022 12:00PM
Aug 10, 2022 12:00PM
Jul 28, 2022 12:00PM
Apr 7, 2022 12:00PM
Mar 28, 2022 12:00PM
Mar 17, 2022 01:00PM
Dec 11, 2021 03:00PM MaaT Pharma Presents Promising Clinical Data from 76 Patients with Acute Graft-vs-Host-Disease Treated with MaaT013 at 63rd ASH Annual Meeting
Dec 1, 2021 01:30PM

325,441 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All